Industries > Pharma > Global Allergic Rhinitis Drugs Market 2017-2027

Global Allergic Rhinitis Drugs Market 2017-2027

Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines

PUBLISHED: 30 May 2017
PAGES: 255
PRODUCT CODE: PHA0196
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0196 Categories: ,

The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.2% in the first half of the forecast period. The market is expected to grow at a CAGR of 3.3% from 2016-2027. The market is estimated at $11.9bn in 2016 and $13.9bn in 2021.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 255-page report you will receive 85 tables and 88 figures – all unavailable elsewhere.

The 255-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Allergic Rhinitis Drugs Market forecasts from 2017-2027

• Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2027 for the following submarkets:
– Intranasal Antihistamines
– Intranasal Corticosteroids
– Oral Antihistamines
– Immunotherapy and Vaccines

• How will leading allergic rhinitis drugs perform to 2027 at world level? Our study forecasts individual revenues of these 27 products:
– Patanase
– Astepro
– Astelin
– Dymista
– Nasonex
– Avamys
– Veramyst
– Flixonase
– Rhinocort
– Omnaris
– Nasacort
– Beconase
– Qnasl
– Zetonna
– Allegra
– Zyrtec
– Claritin
– Xyzal
– Allelock
– Clarinex
– Ebastel
– Talion
– Staloral
– Alutard SQ
– Grazax
– Ragwitek
– Generic Azelastine

Global Allergic Rhinitis Drugs Market 2017-2027

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– EU5 – Germany, UK, France, Italy and Spain
– China
– Japan
– India
– Russia
– Brazil
– Rest of the World

• Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:
GlaxoSmithKline (GSK)
– Merck & Co
– Sanofi
– Johnson & Johnson
– ALK-Abello
– UCB
– Kyowo Hako Kirin
– Stallergenes Greer

• This report discusses the trends and development in the allergic rhinitis pipeline

• Our study discusses strengths, weaknesses, opportunities and threats as well as porter’s five forces analysis of the global allergic rhinitis drugs market

Visiongain’s study is intended for anyone requiring commercial analyses for the global allergic rhinitis drugs market. You find data, trends and predictions.

Buy our report today Global Allergic Rhinitis Drugs Market 2017-2027: Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2017-2027


Latest Pharma news

Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022

READ

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

READ

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

READ

Categories